Cite
HARVARD Citation
Jabulowsky, R. et al. (n.d.). 1238TiPA first-in-human phase I/II clinical trial assessing novel mRNA-lipoplex nanoparticles encoding shared tumor antigens for immunotherapy of malignant melanoma. Annals of oncology. p. . [Online].